About Us
Michael G. LoPresti, Ph.D.
Founder and CEO, GinePro LLC
Do you need experienced and flexible bilingual support with clinical research or other value evidence generation for Japan? If so, you have come to the right place!
With over 20 years of experience in Japan, we have successfully managed countless healthcare evidence generation studies for medical devices, regenerative medicines, and pharmaceuticals. We have also supported with English-language medical writing for numerous HEOR studies in Japan.
Our core focus is clinical research and evidence generation for medical devices and equipment, digital therapies, and regenerative medicines therapies, including gene therapies and cellular therapies. We also selectively support for market access and HEOR studies related to pharmaceutical products.
Contact us today to generate greater certainty for your studies in Japan!
Our Mission
Much like the resilient juniper tree, or ‘ginepro’ in Italian, that thrives in challenging environments, we are committed to bridging challenging cultural and contextual gaps to enable effective planning and execution of value evidence generation for medical technologies in Japan.
GinePro Overview
Company name:
President:
Location:
Collaborators:
Affiliations:
GinePro LLC (ジネプロ合同会社）
Michael LoPresti (ロプレスティ マイケル)
Tokyo, JAPAN
ArkMS, INTAGE Healthcare, Junicon / JuniConnect, etc.
ISPOR Medical Device Interest Group
ISPOR Digital Therapies Interest Group
ISPOR Japan Chapter
International Clinical Evidence Professional Society (Board Member)
Japanese Society for QOL-PRO Research
Society for Regulatory Science of Medical Products (Japan)
Core Services:
Market access support, clinical research, HEOR, medical writing, etc.
Advisor:
Masakazu Fujii, M.D.
Japan-based orthopedic surgeon and rehabilitation therapy expert
Healthcare evidence generation & access support for Japan.
© 2024-2025 GinePro LLC. All rights reserved.
